A veteran stock market enthusiast📈sharing real-time stock market trends and trading information📊Follow me and I will help you achieve financial freedom!
$NFE
Target Price: $4.50
Short positions exceed 60 million, accompanied by millions of shares traded. (Unknown reason)
$1.60 is a key support level; if it holds, coupled with news and earnings reports, there is significant upside potential.
$FGL
Target Price: $1.4
Support Level: $0.42
Positive Factors: A $245 million solar + energy storage project has been finalized in Malaysia.
Trading Volume: Trading volume has exceeded 42 million shares.
A list of hot stocks compiled over the weekend (potential returns up to 300%)
Will be shared to a WhatsApp group before the market opens tomorrow.
Seize the opportunity!
👉https://t.co/gHIGOhPYQf
Reply "6" to join for free.
$BYND $LUMN $XHLD $FRGT $ASST
$HKD $CAN $RR
$DFSC
Revenue surged, driven by global geopolitical tensions and a boom in AI infrastructure investment; defense spending increased by 394%.
Funding supports expansion plans; low beta characteristics enhance defensive capabilities.
Target price: $9.50
$ARDX
Third-quarter revenue surged 92%,
The CEO projects fourth-quarter sales to exceed $125 million;
Leveraging the increasing penetration of IBSRELA and the strong clinical data of XPHOZAH,
A target price of $8 is set.
$VCIG
The results of its AI and cybersecurity strategy have been implemented, and the company has begun its transformation towards military-grade AI computing servers (a high-value-added field).
Target Price: $6.3
$ARBB
Deeply involved in AI+IoT agriculture, exploring demand in Malaysia;
Subsidiary boasts 2,000 acres of land under construction, $53 million in sales, and AI robots;
Target price: $10
$XHLD
VSEE can drive revenue growth with new products (such as Xyvid Pro) and strategic partnerships.
85% insider ownership and no debt.
Target price: $0.70
$VSEE
Q2 revenue increased by over 100% year-over-year.
A $10 million remote radiology contract will contribute substantial recurring revenue,
and current trading volume is outstanding.
Target price: $2.
$HOLO
From a market perspective, the hype surrounding quantum technology,
limited outstanding shares,
and the newly announced capital plan
are all intertwined.
Target price: $5.60
$GNPX
Shares rise on new cancer treatment data
Alert: Partners to present positive preclinical data for REQORSA at conference on October 25th
Target price: $18
$VTYX
VTYX has performed well recently.
On the one hand, it's supported by positive clinical data.
On the other hand, market momentum is strong.
There's a high probability of further upside in the short term.
Target price: $11
$VSEE
The signing of a $10 million, multi-year teleradiology contract is a significant boost to VSee's growth.
Positive financial news also emerged, with profit margins and cash flow steadily improving and revenue increasing nearly 100% year-over-year.
Target Price: $2
$DNUT
The current exponentially increasing trading volume is very similar to the volume performance of $BYND on Monday.
Operationally, the target price can be set at $7.5
$BYND
All short squeeze factors are currently in place.
Pre-market trading volume has exceeded 100 million.
Target price set at $2.50.
Also, to ensure risk control, a strict stop-loss at $0.7 is recommended.